Letters submitted by BDN readers are verified by BDN Opinion Page staff. Send your letters to [email protected]
Maine has one of the oldest populations in the country and we face a critical health challenge: obesity. Maine has approximately 370,000 people or over 25 percent of our population on Medicare, which is higher than the national average of about 19 percent. As our community grows older, addressing this issue becomes increasingly urgent. Medicare coverage should include anti-obesity medications to support our elderly population in achieving better health outcomes.
Obesity contributes significantly to chronic conditions such as diabetes, heart disease, and joint problems, all of which are prevalent among seniors. Access to anti-obesity medications can help mitigate these risks, improve quality of life, and reduce healthcare costs in the long term.
Many older adults struggle with weight management despite efforts to maintain healthy lifestyles. Medicare’s current exclusion of anti-obesity medications limits treatment options and hinders preventive care efforts. By expanding coverage to include these medications, Medicare can better support the health and wellbeing of Maine’s elderly.
Addressing obesity aligns with preventive healthcare goals, promoting independence and reducing the burden on our healthcare system. It’s time to recognize obesity as a chronic condition deserving of comprehensive treatment under Medicare.
Let’s prioritize the health of Maine’s seniors by advocating for inclusive Medicare coverage that addresses the multifaceted challenges of obesity. Together, we can ensure a healthier future for our aging population.
Brian Ouellette Sr.
China
